PTK2 and breast cancer: ROCK isoforms differentially regulate the RhoA/ROCK1/p-MLC and RhoA/ROCK2/p-cofilin pathways in a coordinated fashion to modulate breast cancer cell motility in a substrate stiffness-dependent manner through integrin β1-activated FAK signaling (58).